Clin2
NCT06822712Possibly a fitRecruiting

Sirolimus-coated balloon for heart artery branch blockages

Coronary Arterial Disease (CAD)

Part of Heart & circulation clinical trials.

This trial tests a new balloon coated with sirolimus (a drug that helps prevent re-blockage) for treating blocked arteries at branch points (bifurcations) in the heart. If you have a blocked artery at a branch point, this study may offer a way to treat the side branch without placing a stent there.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
250 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old.
  • You have chest pain, shortness of breath, or had a heart attack that happened more than 7 days ago and is now stable.
  • You need treatment for a blocked artery where the block is at a branch point (bifurcation) and the side branch is also blocked.
  • You are not allergic to sirolimus, paclitaxel, or contrast dye, and you do not have a bleeding disorder that prevents you from taking blood thinners.
  • You have not had a stroke, stomach ulcer, or major bleeding in the last 6 months.
  • You are willing to come back for follow-up imaging tests of your heart.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06669793Not yet recruiting
Biolimus-coated balloon for new coronary artery blockages

This study tests a special balloon coated with a medicine (biolimus) to treat newly formed blockages in the heart's arteries. The balloon is used during a procedure to open the artery and may help keep it open longer.

NCT06866756Recruiting
Comparing two drug-coated balloons for heart artery treatment

This trial is comparing sirolimus and paclitaxel drug-coated balloons to treat new blockages or restenosis (re-blockage) in heart arteries. It aims to see which type of balloon works better for opening arteries without leaving a metal stent behind.

Vigo, Pontevedra
NCT06928883Not yet recruiting
Drug-coated balloon for non-blocking heart plaque after a heart attack

This study is testing a special balloon that releases a drug (sirolimus) to treat fatty plaques in heart arteries that are not yet blocking blood flow. The hope is that this treatment can stabilize or even shrink these plaques, reducing future risk of heart attacks. If you have recently had a heart attack and have other non-obstructive plaques, this trial might offer a new approach.

Lugano
NCT07444957Recruiting
Safety of a drug-coated balloon for heart artery blockages

This study tests a special balloon coated with a drug called sirolimus to open blocked heart arteries. It may be an option for people with coronary artery disease who need a less invasive treatment.

Vigo, Pontevedra
NCT06959524Recruiting
Drug-coated balloon for new coronary blockages

This trial is testing a special balloon coated with medication to treat newly formed blockages in the heart's arteries. The medication may help keep the artery open after the balloon opens it during a standard procedure.

Jonesboro, Arkansas
NCT06618248Recruiting
Sirolimus balloon for heart artery blockages at branches

This study tests a balloon coated with sirolimus (a medicine to prevent re-narrowing) to treat blockages in branch arteries of the heart. It may help patients who need a stent in the main artery but have a side branch that can be treated with this balloon instead of a stent.

Beijing, Beijing Municipality

Hear when a new Coronary Arterial Disease (CAD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.